← Insider buys
REPL

Replimune Group, Inc. · Healthcare

Director Kapil Dhingra sold $1.8M of Replimune Group, Inc.

Sold$1,822,395
$45.56Price
40,000Shares
−100%Stake

What REPL did after the filing

Prices for REPL after this filing aren't in yet.

Traded Mon, Dec 7. Filed Wed, Dec 9, 7:48 PM ET, after the close. Not investment advice.